37 related articles for article (PubMed ID: 34629425)
1. Identification of symptom clusters and sentinel symptoms during the first cycle of chemotherapy in patients with lung cancer.
Luo Y; Mao D; Zhang L; Yang Z; Miao J; Zhang L
Support Care Cancer; 2024 May; 32(6):385. PubMed ID: 38801450
[TBL] [Abstract][Full Text] [Related]
2. Sleep Disturbance as a Mediator of Lung Cancer Stigma on Psychological Distress and Physical Symptom Burden.
Williamson TJ; Garon EB; Irwin MR; Choi AK; Goldman JW; Stanton AL
Psychosom Med; 2024 May; 86(4):334-341. PubMed ID: 38436657
[TBL] [Abstract][Full Text] [Related]
3. Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial.
Jung W; Ahn A; Lee G; Kong S; Kang D; Lee D; Kim TE; Shim YM; Kim HK; Cho J; Cho J; Shin DW
JMIR Res Protoc; 2024 Feb; 13():e54707. PubMed ID: 38349712
[TBL] [Abstract][Full Text] [Related]
4. Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets.
Yang M; Hu X; Tang B; Deng F
Heliyon; 2024 Jan; 10(2):e24811. PubMed ID: 38312618
[TBL] [Abstract][Full Text] [Related]
5. Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping review.
Güven DC; Thong MS; Arndt V
J Cancer Surviv; 2024 Jan; ():. PubMed ID: 38175366
[TBL] [Abstract][Full Text] [Related]
6. Non-pharmaceutical interventions to optimize cancer immunotherapy.
Boesch M; Baty F; Rassouli F; Kowatsch T; Joerger M; Früh M; Brutsche MH
Oncoimmunology; 2023; 12(1):2255459. PubMed ID: 37791231
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Johns AC; Yang M; Wei L; Grogan M; Spakowicz D; Patel SH; Li M; Husain M; Kendra KL; Otterson GA; Rosko AE; Andersen BL; Carbone DP; Owen DH; Presley CJ
Oncologist; 2023 Aug; 28(8):e625-e632. PubMed ID: 37085156
[TBL] [Abstract][Full Text] [Related]
8. Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival.
Andersen BL; Myers J; Blevins T; Park KR; Smith RM; Reisinger S; Carbone DP; Presley CJ; Shields PG; Carson WE
PLoS One; 2023; 18(2):e0282206. PubMed ID: 36827396
[TBL] [Abstract][Full Text] [Related]
9. Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer.
Rodriguez-Gonzalez A; Hernández R; Cruz-Castellanos P; Fernández-Montes A; Castillo-Trujillo O; Muñoz MM; Cano-Cano JM; Corral MJ; Esteban E; Jiménez-Fonseca P; Calderon C
Health Qual Life Outcomes; 2023 Feb; 21(1):15. PubMed ID: 36800957
[TBL] [Abstract][Full Text] [Related]
10. Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer.
Obeng-Gyasi S; Li Y; Carson WE; Reisenger S; Presley CJ; Shields PG; Carbone DP; Ceppa DP; Carlos RC; Andersen BL
JAMA Netw Open; 2022 Jul; 5(7):e2221626. PubMed ID: 35797043
[TBL] [Abstract][Full Text] [Related]
11. Functional Trajectories and Resilience Among Adults With Advanced Lung Cancer.
Presley CJ; Arrato NA; Shields PG; Carbone DP; Wong ML; Benedict J; Reisinger SA; Han L; Gill TM; Allore H; Andersen BL; Janse S
JTO Clin Res Rep; 2022 Jun; 3(6):100334. PubMed ID: 35719868
[TBL] [Abstract][Full Text] [Related]
12. Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer.
Valentine TR; Presley CJ; Carbone DP; Shields PG; Andersen BL
Health Psychol; 2022 Jun; 41(6):379-388. PubMed ID: 35604701
[TBL] [Abstract][Full Text] [Related]
13. Cancer Treatment During COVID-19: Resilience of Individuals With Advanced Non-Small Cell Lung Cancer Versus Community Controls.
Arrato NA; Lo SB; Coker CA; Covarrubias JJ; Blevins TR; Reisinger SA; Presley CJ; Shields PG; Andersen BL
J Natl Compr Canc Netw; 2022 Feb; 20(2):118-125. PubMed ID: 35130505
[TBL] [Abstract][Full Text] [Related]
14. Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description of those with moderate to severe depressive symptoms.
Andersen BL; Valentine TR; Lo SB; Carbone DP; Presley CJ; Shields PG
Lung Cancer; 2020 Jul; 145():195-204. PubMed ID: 31806360
[TBL] [Abstract][Full Text] [Related]
15. Anxiety After Diagnosis Predicts Lung Cancer-Specific and Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer: A Population-Based Cohort Study.
Vodermaier A; Lucas S; Linden W; Olson R
J Pain Symptom Manage; 2017 Jun; 53(6):1057-1065. PubMed ID: 28063862
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
17. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
[TBL] [Abstract][Full Text] [Related]
18. Psychological Symptom Trajectories and Non-Small Cell Lung Cancer Survival: A Joint Model Analysis.
Andersen BL; McElroy JP; Carbone DP; Presley CJ; Smith RM; Shields PG; Brock GN
Psychosom Med; 2022 Feb-Mar 01; 84(2):215-223. PubMed ID: 34629425
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
